Evidence map›Paper›PMID 31857682›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas.

Lysandra Voltaggio, W Glenn McCluggage, Jeffrey S Iding, Brock Martin, Teri A Longacre, Brigitte M Ronnett

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Human papillomavirus-associated rectal adenocarcinoma.Journal of surgical case reports · 2026
    Article
  6. Review
  7. New histopathological and molecular findings in gynecological cancers.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Review
  8. Targeted therapies in primary vaginal cancer.Journal of cancer research and clinical oncology · 2025
    Article
  9. Review
  10. The relationship between long non-coding geneCancer biology & therapy · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Adenosquamous carcinoma in situ of the anus: a case series.Virchows Archiv : an international journal of pathology · 2023
    Article
  15. Review
  16. Progress in the pathological arena of gynecological cancers.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Lysandra VoltaggioDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lvoltag1@jhmi.edu.
W Glenn McCluggageDepartment of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
Jeffrey S IdingDepartment of Pathology, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
Brock MartinDepartment of Pathology, Stanford University, Stanford, CA, USA.
Teri A LongacreDepartment of Pathology, Stanford University, Stanford, CA, USA.
Brigitte M RonnettDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins Medicine · USStanford University · USBelfast Health and Social Care Trust · GBMedStar Franklin Square Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) is an oncogenic virus associated with the development of several human cancers. Primary vaginal, vulvar, and anal adenocarcinomas are rare and, to date, have rarely been shown to be associated with HPV infection. We report a series of nine HPV-related adenocarcinomas of the lower anogenital tract distal to the cervix. The tumors involved the vagina (4), anorectum (3), and vulva (2). Two of the three anorectal cases involved men. Patients presented with a vulvar or vaginal mass/nodule, painless rectal bleeding, or during screening colonoscopy. Lesions ranged in size from 3.2 to 8.4 cm. The most salient morphologic characteristic was the presence of papillary or villiform/villoglandular architecture in all cases. Tumors displayed features similar to those of usual type high-risk HPV-related endocervical adenocarcinoma, namely, mucinous or mucin-poor (pseudoendometrioid) features or a hybrid of these, with columnar cells with crowded, cigar-shaped to ovoid irregular nuclei. Mitoses (mostly apical) and apoptotic bodies were easily identified. Adenosis was present in two vaginal cases. One anal tumor featured abundant intracytoplasmic mucin that was multivacuolated in some areas imparting a "clear cell"-like appearance. All tumors were diffusely and strongly positive for p16. Seven of seven tested cases were positive for high-risk HPV by in situ hybridization or polymerase chain reaction. Follow-up information, available in five patients, revealed two local recurrences but no tumor related deaths or distant metastases. We report the first well-documented series of HPV-associated primary adenocarcinomas of the vagina, vulva, and anorectum and broaden the spectrum of HPV-related neoplasia involving the lower anogenital tract in both women and men.

Indexed as

AdenocarcinomaAdultAgedColorectal NeoplasmsFemaleHumansMaleMiddle AgedPapillomavirus InfectionsUrogenital Neoplasms

Identifiers

PMID31857682
OpenAlexW2994849252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.